However, in contrast to gemcitabine-treated DLBCL cells, there was no shift for proteins in the ssDNA binding RPA complex or CHEK1 (Supplementary Fig. 7D) in cisplatin-treated breast cancer cells. The gene discussed is CHEK1; the disease is breast cancer.